David E. Riley
Impact in
- Neurology top 0.2%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
- Neurological diseases and metabolism
-
- Genetic Neurodegenerative Diseases
Papers in
- Neurology 52
- Parkinson's Disease Mechanisms and Treatments 39
- Neurological disorders and treatments 27
- Botulinum Toxin and Related Neurological Disorders 15
- Neurological diseases and metabolism 5
-
- Genetic Neurodegenerative Diseases 6
- Nuclear Receptors and Signaling 4
- Co-authors
- Anthony E. Lang (13 shared papers)Brian N. Maddux (6 shared papers)Irene Litvan (11 shared papers)Stephen G. Reich (10 shared papers)Kailash P. Bhatia (2 shared papers)Dustin A. Heldman (4 shared papers)Melissa J. Armstrong (2 shared papers)Oleh Hornykiewicz (1 shared paper)
- Journals
- Neurology (13 papers)Movement Disorders (7 papers)Parkinsonism & Related Disorders (4 papers)Clinical Neuropharmacology (3 papers)Annals of the New York Academy of Sciences (3 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
David E. Riley
65 papers receiving 3.8k citations
David E. Riley's Hit Papers
Peers
Comparison fields: 5 of 131
- Neurology 2.7k
- Neurology 712
- Cellular and Molecular Neuroscience 831
- Psychiatry and Mental health 632
- Physiology 734
Countries citing papers authored by David E. Riley
This map shows the geographic impact of David E. Riley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Riley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Riley more than expected).
Fields of papers citing papers by David E. Riley
This network shows the impact of papers produced by David E. Riley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Riley. The network helps show where David E. Riley may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Riley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Criteria for the diagnosis of corticobasal degeneration Hit paper breakdown → | 2013 | 1177 |
| 2 | 1990 | 412 | |
| 3 | 2009 | 196 | |
| 4 | 2007 | 186 | |
| 5 | 2007 | 168 | |
| 6 | 1996 | 138 | |
| 7 | 1998 | 120 | |
| 8 | 1993 | 109 | |
| 9 | 1989 | 101 | |
| 10 | 2010 | 94 | |
| 11 | 2001 | 79 | |
| 12 | Induction of cell growth regulatory genes by p53. | 1996 | 74 |
| 13 | Clinical diagnostic criteria. | 2000 | 67 |
| 14 | 2006 | 60 | |
| 15 | 2002 | 57 | |
| 16 | 1990 | 56 | |
| 17 | 1994 | 53 | |
| 18 | 1991 | 46 | |
| 19 | 2012 | 42 | |
| 20 | 1988 | 42 |
About David E. Riley
David E. Riley is a scholar working on Neurology, Cellular and Molecular Neuroscience, Neurology, Psychiatry and Mental health and Clinical Psychology, having authored 66 papers that have together received 3.9k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (39 papers), Neurological disorders and treatments (27 papers), Botulinum Toxin and Related Neurological Disorders (15 papers), Obsessive-Compulsive Spectrum Disorders (7 papers), Genetic Neurodegenerative Diseases (6 papers), Autism Spectrum Disorder Research (5 papers), Neurological diseases and metabolism (5 papers) and Nuclear Receptors and Signaling (4 papers). The work is most often cited by research in Neurology (2.7k citations), Neurology (712 citations), Cellular and Molecular Neuroscience (831 citations), Psychiatry and Mental health (632 citations) and Physiology (734 citations). David E. Riley has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Anthony E. Lang, Brian N. Maddux, Irene Litvan, Stephen G. Reich, Kailash P. Bhatia, Dustin A. Heldman, Melissa J. Armstrong, Oleh Hornykiewicz, Murray Grossman and Joseph P. Giuffrida. Their work appears in journals such as Neurology, Movement Disorders, Parkinsonism & Related Disorders, Clinical Neuropharmacology and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.